Prefrontal cortical connectivity and coupling of infraslow oscillation in the resting human brain: a 2-channel broadband NIRS study. Issue 3 (4th August 2022)

• Record Type: Journal Article
• Authors: Shahdadian, Sadra; Wang, Xinlong; Kang, Shu; Carter, Caroline; Chaudhari, Akhil; Liu, Hanli
• Is Part Of: Cerebral cortex communications. Volume 3:Issue 3(2022)
• Publication Date: 2022-08-04
• Subjects: broadband near-infrared spectroscopy -- infraslow oscillation -- metabolic and hemodynamic coupling -- prefrontal cortical connectivity -- resting state functional connectivity; Cerebral cortex -- Periodicals; Brain -- Periodicals; 612.825
• DOI: 10.1093/texcom/tgac033
• Languages: English
• ISSNs: 2632-7376

Abstract

Abstract: The resting-state infraslow oscillation (ISO) of the cerebral cortex reflects the neurophysiological state of the human brain. ISO results from distinct vasomotion with endogenic (E), neurogenic (N), and myogenic (M) frequency bands. Quantification of prefrontal ISO in cortical hemodynamics and metabolism in the resting human brain may facilitate the identification of objective features that are characteristic of certain brain disorders. The goal of this study was to explore and quantify the prefrontal ISO of the cortical concentration changes of oxygenated hemoglobin (Δ[HbO]) and redox-state cytochrome c oxidase (Δ[CCO]) as hemodynamic and metabolic activity metrics in all 3 E/N/M bands. Two-channel broadband near-infrared spectroscopy (2-bbNIRS) enabled measurements of the forehead of 26 healthy young participants in a resting state once a week for 5 weeks. After quantifying the ISO spectral amplitude (SA) and coherence at each E/N/M band, several key and statistically reliable metrics were obtained as features: (i) SA of Δ[HbO] at all E/N/M bands, (ii) SA of Δ[CCO] in the M band, (iii) bilateral connectivity of hemodynamics and metabolism across the E and N bands, and (iv) unilateral hemodynamic–metabolic coupling in each of the E and M bands. These features have promising potential to be developed as objective biomarkers for clinical applications in the future.